Flu News and Research

RSS
Anlit Advanced Nutrition Supplements to present new products at Vitafoods Europe 2012

Anlit Advanced Nutrition Supplements to present new products at Vitafoods Europe 2012

Dutch government grants export license allowing publication of controversial H5N1 study

Dutch government grants export license allowing publication of controversial H5N1 study

CityBusters battle illness on public transit

CityBusters battle illness on public transit

LifePoint Hospitals first quarter revenues increase 12.2% to $851.0 million

LifePoint Hospitals first quarter revenues increase 12.2% to $851.0 million

Senate committee questions federal officials about dual-use research of concern procedures

Senate committee questions federal officials about dual-use research of concern procedures

Funders should follow lead of U.S. in creating policies for scientific research oversight

Funders should follow lead of U.S. in creating policies for scientific research oversight

Viewpoints: Ma. health law trips up even bosses offering insurance; Traumatic brain disease may be complicating veterans' recoveries

Viewpoints: Ma. health law trips up even bosses offering insurance; Traumatic brain disease may be complicating veterans' recoveries

U.S. government must be prepared to handle dual use research of concern

U.S. government must be prepared to handle dual use research of concern

Australian Government must take the lead in tackling antibiotic resistance: NPS Board Chair Dr Janette Randall address to the National Press Club

Australian Government must take the lead in tackling antibiotic resistance: NPS Board Chair Dr Janette Randall address to the National Press Club

Dutch government rule export permit required to publish controversial bird flu study

Dutch government rule export permit required to publish controversial bird flu study

Text-message intervention may help boost flu vaccination rates in children

Text-message intervention may help boost flu vaccination rates in children

Rep. Sensenbrenner sends second letter inquiring about U.S. government's review of controversial H5N1 studies

Rep. Sensenbrenner sends second letter inquiring about U.S. government's review of controversial H5N1 studies

Text messaging increases flu vaccination coverage in low-income children

Text messaging increases flu vaccination coverage in low-income children

Process of reviewing controversial experiments for publication must be streamlined in future

Process of reviewing controversial experiments for publication must be streamlined in future

U.S. gives go-ahead on publication of H5N1 research; Dutch regulators continue to debate

U.S. gives go-ahead on publication of H5N1 research; Dutch regulators continue to debate

Women & Infants named lead center in 14-site study of cytomegalovirus

Women & Infants named lead center in 14-site study of cytomegalovirus

Health Management first quarter net revenue increases 18.4% to $1.485B

Health Management first quarter net revenue increases 18.4% to $1.485B

New drug can prevent exacerbations of asthma due to common cold: Trial report

New drug can prevent exacerbations of asthma due to common cold: Trial report

New data shows consolidation of interferon-free revolution in HCV treatment

New data shows consolidation of interferon-free revolution in HCV treatment

NSABB calls for global guidelines for conducting, communicating research involving dangerous pathogens

NSABB calls for global guidelines for conducting, communicating research involving dangerous pathogens

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.